Theseus Pharmaceuticals, Inc.

NasdaqGS:THRX Voorraadrapport

Marktkapitalisatie: US$180.7m

Theseus Pharmaceuticals Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur2.7yrs

Recente managementupdates

Recent updates

Theseus Pharmaceuticals: Biotech Buyout Remains Attractive At $4.06 Because Of 2-Part CVR

Feb 01

Theseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plans

Aug 18
Theseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plans

Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth

May 05
Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth

Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth

Dec 07
Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth

Theseus Pharmaceuticals GAAP EPS of -$0.30 in-line

Aug 11

Here's Why We're Not Too Worried About Theseus Pharmaceuticals' (NASDAQ:THRX) Cash Burn Situation

Apr 22
Here's Why We're Not Too Worried About Theseus Pharmaceuticals' (NASDAQ:THRX) Cash Burn Situation

CEO

Theseus Pharmaceuticals heeft geen CEO, of we hebben geen gegevens over hen.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Iain Dukes
Co-Founder & Chairman5.7yrsUS$247.97k0.87%
$ 1.6m
Bradford Dahms
Presidentless than a yearUS$2.05m0.014%
$ 24.9k
Carl Gordon
Director5.7yrsUS$159.62k0%
$ 0
Donald Hayden
Lead Independent Director1.8yrsUS$365.58k0.022%
$ 40.6k
Steven Stein
Independent Director1.3yrsUS$279.48k0%
$ 0
Kathy Yi
Independent Director2.7yrsUS$180.00k0%
$ 0
Michael Rome
Independent Director3.1yrsgeen gegevensgeen gegevens

2.7yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van THRX wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.7 jaar), wat duidt op een nieuw bestuur.